Enanta Pharmaceuticals (ENTA) Current Deferred Tax Assets (2014 - 2016)

Enanta Pharmaceuticals' Current Deferred Tax Assets history runs 3 years deep, the most recent figure standing at $1.1 million for Q2 2016.

• Quarterly Current Deferred Tax Assets fell 34.72% year-over-year to $1.1 million in Q2 2016, while the trailing twelve-month figure through Jun 2016 was $1.1 million (down 34.72% YoY) and the FY2015 annual result came in at $1.4 million, down 86.99% from the prior year.
• Current Deferred Tax Assets was $1.1 million for Q2 2016 at Enanta Pharmaceuticals, down from $1.6 million in the prior quarter.
• Across five years, Current Deferred Tax Assets topped out at $11.2 million in Q2 2014 and bottomed at $1.1 million in Q2 2016.
• A 3-year average of $3.6 million and a median of $1.6 million in 2015 frame the typical range for Current Deferred Tax Assets.
• Peak annual rise in Current Deferred Tax Assets reached 17.28% in 2015, while the deepest fall reached 86.99% in 2015.
• Enanta Pharmaceuticals' Current Deferred Tax Assets stood at $1.3 million in 2014, then climbed by 17.28% to $1.6 million in 2015, then fell by 27.45% to $1.1 million in 2016.
• Business Quant data shows ENTA's Current Deferred Tax Assets at $1.1 million in Q2 2016, $1.6 million in Q1 2016, and $1.6 million in Q4 2015.